Discover

OGEN
Oragenics, Inc.
0.60
200 x 0.59
400 x 0.60
bid
ask
-
0.01
1.81%
12:06 PM
timesize
Ytd-23.71%
1y-58.67%
0.55
day range
0.60
0.50
52 week range
1.58
Open0.61Prev Close0.61Low0.55High0.60Mkt Cap2.69M
Vol26.91KAvg Vol53.63KEPS-4.95P/EN/AForward P/E-0.03
Beta0.48Short Ratio0.43Inst. Own11.13%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg0.60200-d Avg0.861yr Est90.00
Income Statement
Operating Expenses2.26M
Research and Development Expense645.47K
Selling, General and Administrative Expense1.61M
Operating Income-2.26M
Interest Expense3.73K
Income Tax Expense-22.62K
Net Income-2.20M
Net Income Common Stock-2.20M
Net Income Common Stock (USD)-2.20M
Consolidated Income-2.20M
Earnings per Basic Share-0.51
Earnings per Basic Share (USD)-0.51
Earnings per Diluted Share-0.51
Earning Before Interest & Taxes (EBIT)-2.22M
Earning Before Interest & Taxes (USD)-2.22M
Weighted Average Shares4.30M
Weighted Average Shares Diluted4.30M
Balance Sheet
Cash and Equivalents6.11M
Cash and Equivalents (USD)6.11M
Current Assets7.49M
Total Assets7.49M
Debt Current56.13K
Total Debt56.13K
Current Liabilities1.31M
Total Liabilities1.31M
Accumulated Retained Earnings (Deficit)-228.83M
Shareholders Equity6.18M
Shareholders Equity (USD)6.18M
Total Debt (USD)56.13K
Trade and Non-Trade Payables1.25M
Cash Flow
Net Cash Flow from Financing-92.00K
Net Cash Flow / Change in Cash & Cash Equivalents1.71M
Issuance (Purchase) of Equity Shares79.21K
Issuance (Repayment) of Debt Securities -171.21K
Net Cash Flow from Investing4.00M
Net Cash Flow - Investment Acquisitions and Disposals4.00M
Net Cash Flow from Operations-2.20M
Share Based Compensation22.39K